FDA Inspection
Direct RxDirect Rx – FDA Inspection, Aug 13, 2015
Record Details
This FDA Inspection record concerns Direct Rx, with an inspection on August 13, 2015, issued by the Center for Drug Evaluation and Research, covering drugs.
- Company
- Direct Rx
- Inspection Date
- August 13, 2015
- Product Type
- Drugs
View Company Profile
ID · 65e13496-acbd-4ade-8392-0303931af198
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 941193
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
FDA Citations
3- 21 CFR 211.188Prepared for each batch, include complete information
- 21 CFR 211.142Written warehousing procedures established/followed
- 21 CFR 211.100(b)SOPs not followed / documented
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Direct Rx
2| Date | Classification | Office | Project area |
|---|---|---|---|
| June 4, 2026 | Not classified | Atlanta District Office | |
| December 15, 2017 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Direct Rx
- FDA Inspection 1324204 - 2026-06-04
- FDA Inspection 1034986 - 2017-12-15
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.